Akebia Therapeutics initiated at Buy by WestPark Capital
Akebia Therapeutics was initiated at Buy by WestPark Capital, according to Benzinga ratings actions.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.